LY 389795
Latest Information Update: 25 Jun 2001
Price :
$50 *
At a glance
- Originator Eli Lilly and Company
- Class Amino acids; Heterocyclic bicyclo compounds; Neuroprotectants; Small molecules
- Mechanism of Action Glutamate agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 25 Jun 2001 No-Development-Reported for Neurological disorders (Prevention) in United Kingdom (Unknown route)
- 25 Jun 2001 No-Development-Reported for Neurological disorders (Prevention) in USA (Unknown route)
- 14 Sep 1998 New profile